Danske Bank Rebalances Portfolio: Trims Amgen Stake, Boosts Northern Trust Position

Key Facts

Danske Bank A S has executed strategic portfolio adjustments, reducing its stake in Amgen Inc. by 18.5% while increasing its position in Northern Trust Corporation (NTRS) by 7.7% during the fourth quarter. The bank acquired an additional 9,700 shares of NTRS, bringing the total value of its holdings to approximately $18.6 million. This accumulation in Northern Trust comes despite recent insider activity where the CFO and other executives sold shares worth millions of dollars. Meanwhile, Amgen continues to show fundamental strength, posting earnings of $5.15 per share and attracting interest from other major institutions like Vanguard Group. These shifts highlight a divergence in institutional strategies across the biotech and financial services sectors. Analysts note that while Danske is rebalancing, the underlying financial health of these entities remains a primary driver for market sentiment.

Version History